Anavex Life Sciences receives FDA clearance to proceed with clinical trial for Fragile X syndrome

Anavex Life Sciences received FDA clearance to proceed with its planned clinical trial under its Investigational New Drug Application for ANAVEX for Fragile X syndrome.

Detected & updated continuously · Source: Nebula